IDO1 and Cognitive impairment: Experimental studies investigating systemic immune activation and sepsis have demonstrated that pharmacological or genetic inhibition of IDO prevents depressive- and anxiety-like behaviors as well as cognitive deficits typically seen alongside acute inflammation (25–27).